OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation
Julie T. Castaneda, Airi Harui, Michael D. Roth
Journal of Neuroimmune Pharmacology (2017) Vol. 12, Iss. 3, pp. 544-554
Open Access | Times Cited: 24

Showing 24 citing articles:

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 88

A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
María S. García‐Gutiérrez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Pharmacological Research (2025) Vol. 213, pp. 107657-107657
Open Access | Times Cited: 2

Endocannabinoid System Components: Overview and Tissue Distribution
Neal Joshi, Emmanuel S. Onaivi
Advances in experimental medicine and biology (2019), pp. 1-12
Closed Access | Times Cited: 113

Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes
Yurii Saroz, Dan T. Kho, Michelle Glass, et al.
ACS Pharmacology & Translational Science (2019) Vol. 2, Iss. 6, pp. 414-428
Open Access | Times Cited: 67

The Immune Endocannabinoid System of the Tumor Microenvironment
Melanie Kienzl, Julia Kargl, Rudolf Schicho
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 8929-8929
Open Access | Times Cited: 38

Cannabinoid Receptor Type 2 Ligands: An Analysis of Granted Patents Since 2010
Benjamin Brennecke, Thais Gazzi, Kenneth Atz, et al.
Pharmaceutical Patent Analyst (2021) Vol. 10, Iss. 3, pp. 111-163
Closed Access | Times Cited: 24

The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma
Nasim Ebrahimi, Nazanin Pazhouhesh Far, Siavash Seifollahy Fakhr, et al.
Environmental Research (2023) Vol. 228, pp. 115914-115914
Closed Access | Times Cited: 9

Patent review of cannabinoid receptor type 2 (CB 2 R) modulators (2016-present)
Miroslav Kosar, Leonard Mach, Erick M. Carreira, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 665-700
Closed Access | Times Cited: 3

Cannabinoid receptors as therapeutic targets for autoimmune diseases: where do we stand?
Elaine D. Gonçalves, Rafael C. Dutra
Drug Discovery Today (2019) Vol. 24, Iss. 9, pp. 1845-1853
Closed Access | Times Cited: 29

Beta-Caryophyllene Modifies Intracellular Lipid Composition in a Cell Model of Hepatic Steatosis by Acting through CB2 and PPAR Receptors
Rosaria Scandiffio, Sara Bonzano, Erika Cottone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6060-6060
Open Access | Times Cited: 8

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
Caitlin R. M. Oyagawa, Sara M. de la Harpe, Yurii Saroz, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 24

Activation of CB2 receptor inhibits pyroptosis and subsequently ameliorates cecal ligation and puncture-induced sepsis
Bin Zhang, Feng Zheng, Anpeng Liu, et al.
International Immunopharmacology (2021) Vol. 99, pp. 108038-108038
Closed Access | Times Cited: 18

Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches
Marta Iozzo, Giovanna Sgrignani, Giuseppina Comito, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3396-3396
Open Access | Times Cited: 16

Cannabinoid Analogue WIN 55212–2 Protects Paraquat-Induced Lung Injury and Enhances Macrophage M2 Polarization
Quan He, Wen Zhang, Jinjuan Zhang, et al.
Inflammation (2022) Vol. 45, Iss. 6, pp. 2256-2267
Open Access | Times Cited: 11

RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB1, CB2, GPR18 and GPR55 cannabinoid receptors
Nathaniel A. K. Glenn, David B. Finlay, Emma R. Carruthers, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 14, pp. 2212-2231
Open Access | Times Cited: 4

Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective
Paola Perin, Alex Mabou Tagne, Paolo Enrico, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 11

Chemical Probes for Investigating the Endocannabinoid System
Annaleah Hanske, Marc Nazaré, Uwe Grether
Current topics in behavioral neurosciences (2024)
Closed Access

Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes
Yurii Saroz, Dan T. Kho, Michelle Glass, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1

CB65 and novel CB65 liposomal system suppress MG63 and Saos-2 osteosarcoma cell growth in vitro
Başak Işıl Zorba, Özge Boyacıoğlu, Tuğba Çağlayan, et al.
Journal of Liposome Research (2023) Vol. 34, Iss. 2, pp. 274-287
Closed Access

Cannabinoids and Breast Cancer
María Soledad Belingeri, Laura Caltana
Elsevier eBooks (2021), pp. 103-122
Closed Access

Page 1

Scroll to top